Home » Topics » BioWorld Science

BioWorld Science
RSS

Harbour BioMed completes phase I study of HBM-9161 in healthy Chinese subjects

Feb. 24, 2020

GlaxoSmithKline presents new ATF-4 inhibitors

Feb. 24, 2020

PureTech Health and Monash University divulge allopregnanolone prodrugs

Feb. 24, 2020

T-cell population is biomarker for beta cell function

Feb. 24, 2020

PD-1 blockade interferes with opioid analgesia

Feb. 24, 2020

Incyte patents new hSTING receptor agonists

Feb. 24, 2020

Orencia approved for prevention of structural damage of joints in current indication of RA

Feb. 24, 2020

FDA grants IND approval for Veyonda plus doxorubicin in soft tissue sarcomas

Feb. 24, 2020

Novel genetically engineered murine model of SCBC

Feb. 24, 2020

DC-007D shows promise as novel thrombolytic in model of focal embolic stroke

Feb. 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...